Costanza Zanetti, PhD student of Prof. Dr. D.S. Krause at the Georg-Speyer-Haus, Institute for Tumour Biology and Experimental Therapy, in Frankfurt (Germany), describes the importance of the bone marrow microenvironment for the progession of leukaemia. Leukaemia White and red blood, as well as platelets are derived from haematopoietic stem cells, which live in the bone […]
Read About Cancer Research From The Scientists
We have exclusive articles written by international scientists who are working on cancer therapies, cures and better detection, explaining their work to our readers.
The commissioning editor for this section is Dr Luisa Robbez-Masson
Imaging cancer using positron emission tomography Positron emission tomography (PET) is a modern imaging technique that has been widely available throughout hospitals and cancer clinics since the 1990s. PET provides very different information to the better-known imaging methods X-ray and CT, which “capture” tumours by showing the internal structure of the body, similar to a […]READ ARTICLE
One of several things that impressed me when I started working in cancer research was the fact that there were still some people who would raise an eyebrow when I answered the question “what do you do?” Though most people are supportive and even enthusiastic about cancer research, there remains a small minority who obstinately […]
Flávia is a biomedical scientist currently working at the Institute of Cancer Research in London, where she performs tumour molecular profiling by Next-Generation Sequencing in the context of clinical trials. She received her BMSc from the Lisbon School of Health Technology and has strong interests in science communication and policy.
Neuroblastoma stage 3 and 4 is a chemotherapy-resistant, highly aggressive disease. High-risk neuroblastoma frequently displays gene defects which fall in three almost non-ovelapping categories. With the use of whole-genome sequencing studies, one of these three groups has been identified as patients with genomic rearrangements associated with an increased expression of a gene called TERT and […]
Born and raised in Greece, Dr Koutroumanidou now lives and work in London. A bench-to-bedside and personalised medicine enthusiast, she is a proud member of the Institute of Cancer Research family currently working on a ground breaking childhood cancer project that aims to establish the first genetic test offered by the NHS to all the children with a solid tumour in the UK.
Professor Nives Pećina-Šlaus, Head of the Laboratory of Neuro-oncology at the Croatian Institute for Brain Research (University of Zagreb) explains how research conducted in her group can impact future brain tumour therapy. Cancer: A Genetic Disease The genetics of cancer (called Cancer Genomics) is nowadays one of the fastest expanding medical specialities and this vast […]
Prof Nives Pecina-Slaus is a Professor at the department of biology and Head of the Laboratory of Neuro-oncology Croatian Institute for Brain Research Medical School, University of Zagreb. She has received her B.S. in 1990. her M.S. in 1992. from the University of Zagreb, Faculty of Math and Sciences, and her Ph. D. in the field of molecular oncology in 1998 from Medical School University of Zagreb. Her main fields of research are cancer genetics, Wnt signalling pathway, brain tumorigenesis, tumour suppressor genes, oncogenes, genetic profiles of brain tumours.
Subscribe to our monthly newsletter
We strongly advise you to talk with a health care professional about specific medical conditions and treatments. The information on our site is meant to be helpful and educational but is not a substitute for medical advice.